About: Chêne Geneviève

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Chêne Geneviève Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	Person
name	Chêne Geneviève Chêne G. Chêne Geneviève Chêne Geneviéve Chêne G. Chéne Geneviéve Chene Geneviève Chêne, Geneviève
personal mailbox	genevieve.chene@isped.u-bordeaux2.fr genevieve.chene@u-bordeaux.fr
familyName	Chêne Chene Chêne Chéne
Given name	G. Geneviève Geneviève Geneviéve
is relates of	http://hub.abes.fr/oup/periodical/jac/2008/volume_62/issue_5/101093jacdkn309/authorship/8 http://hub.abes.fr/oup/periodical/cid/2003/volume_37/issue_2/101086375844/authorship/2 http://hub.abes.fr/oup/periodical/cid/2004/volume_39/issue_2/101086422141/authorship/4 http://hub.abes.fr/oup/periodical/ije/2004/volume_34/issue_1/101093ijedyh307/authorship/10 http://hub.abes.fr/oup/periodical/aje/2001/volume_153/issue_4/101093aje1534386/authorship/2 http://hub.abes.fr/oup/periodical/jac/2010/volume_65/issue_11/101093jacdkq327/authorship/11 http://hub.abes.fr/oup/periodical/cid/2009/volume_49/issue_12/101086648445/authorship/9 http://hub.abes.fr/oup/periodical/jac/2010/volume_65/issue_10/101093jacdkq282/authorship/7 http://hub.abes.fr/oup/periodical/jid/2002/volume_185/issue_4/101086338929/authorship/3 http://hub.abes.fr/oup/periodical/cid/2002/volume_34/issue_2/101086324354/authorship/2 http://hub.abes.fr/oup/periodical/cid/2009/volume_48/issue_5/101086596766/authorship/11 http://hub.abes.fr/oup/periodical/cid/2009/volume_49/issue_9/101086630210/authorship/13 http://hub.abes.fr/oup/periodical/ije/2001/volume_30/issue_4/101093ije304864/authorship/2 http://hub.abes.fr/oup/periodical/aje/2001/volume_154/issue_1/101093aje154175/authorship/4 http://hub.abes.fr/oup/periodical/jac/2008/volume_62/issue_5/101093jacdkn335/authorship/8 http://hub.abes.fr/oup/periodical/jac/2009/volume_64/issue_1/101093jacdkp141/authorship/10 http://hub.abes.fr/oup/periodical/jid/2002/volume_186/issue_5/101086342047/authorship/6 http://hub.abes.fr/oup/periodical/ije/2010/volume_39/issue_1/101093ijedyp300/authorship/10 http://hub.abes.fr/oup/periodical/jac/2004/volume_53/issue_6/101093jacdkh200/authorship/4 http://hub.abes.fr/oup/periodical/cid/2009/volume_49/issue_7/101086605594/authorship/11 http://hub.abes.fr/oup/periodical/aje/2005/volume_161/issue_6/101093ajekwi065/authorship/5 http://hub.abes.fr/bmj/periodical/bmj/2004/volume_328/issue_7434/B36D7AEB983B14DEE053120B220A6B62/authorship/6 http://hub.abes.fr/cairn/periodical/rfas/2019/issue_rfas193/D33A14C54C8A2E15E053120B220A6889/authorship/7
is Author of	Incidence of and Risk Factors for Adverse Drug Reactions in a Prospective Cohort of HIV-Infected Adults Initiating Protease Inhibitor—Containing Therapy Predictors of Long-Term Increase in CD4+ Cell Counts in Human Immunodeficiency Virus-Infected Patients Receiving a Protease Inhibitor-Containing Antiretroviral Regimen Incidence of primary opportunistic infections in two human immunodeficiency virus-infected French clinical cohorts Modeling Changes in CD4-positive T-Lymphocyte Counts after the Start of Highly Active Antiretroviral Therapy and the Relation with Risk of Opportunistic Infections The Aquitaine Cohort, 1996-1997 Causes of death among human immunodeficiency virus (HIV)-infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS Impact of Discontinuation of Initial Protease Inhibitor Therapy on Further Virological Response in a Cohort of Human Immunodeficiency Virus-Infected Patients Changes in Cancer Mortality among HIV-Infected Patients: The Mortalité 2005 Survey Switch from zidovudine- to non-zidovudine-containing regimens is associated with modest haematological improvement and no obvious clinical benefit: a substudy of the ANRS 099 ALIZE trial Long-Term Evolution and Determinants of Renal Function in HIV-Infected Patients Who Began Receiving Combination Antiretroviral Therapy in 1997-1999, ANRS CO8 APROCO-COPILOTE Role of Uncontrolled HIV RNA Level and Immunodeficiency in the Occurrence of Malignancy in HIV-Infected Patients during the Combination Antiretroviral Therapy Era: Agence Nationale de Recherche sur le Sida (ANRS) CO3 Aquitaine Cohort Interaction between HIV-1 and HCV infections: towards a new entity? Risk Factors for Coronary Heart Disease in Patients Treated for Human Immunodeficiency Virus Infection Compared with the General Population A randomized trial of two-drug versus three-drug tenofovir-containing maintenance regimens in virologically controlled HIV-1 patients Prognostic Value of Cross-sectional Anthropometric Indices on Short-term Risk of Mortality in Human Immunodeficiency Virus-infected Adults in Abidjan, Côte d'Ivoire High Rate of Virologic Suppression with Raltegravir Plus Etravirine and Darunavir/Ritonavir among Treatment-Experienced Patients Infected with Multidrug-Resistant HIV: Results of the ANRS Higher HIV-1 DNA associated with lower gains in CD4 cell count among patients with advanced therapeutic failure receiving optimized treatment (ANRS 123—ETOILE) Lopinavir/ritonavir monotherapy versus current treatment continuation for maintenance therapy of HIV-1 infection: the KALESOLO trial Factors Associated with Mortality in Human Immunodeficiency Virus Type 1-Infected Adults Initiating Protease Inhibitor-Containing Therapy: Role of Education Level and of Early Transaminase Level Elevation (APROCO-ANRS EP11 Study) Use of a Bayesian Approach to Decide When to Stop a Therapeutic Trial: The Case of a Chemoprophylaxis Trial in Human Immunodeficiency Virus Infection Causes of death in HIV-infected women: persistent role of AIDS. The ‘Mortalité 2000 & 2005’ Surveys (ANRS EN19) HIV-2 integrase gene polymorphism and phenotypic susceptibility of HIV-2 clinical isolates to the integrase inhibitors raltegravir and elvitegravir in vitro Appropriateness Assessment and Support Programme at a University Hospital (CHU) in Bordeaux : Towards an Operational Model for the Implementation of Appropriateness at a Healthcare Institution

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata